Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 68.0536.8019.3923.4127.87

What is the latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS is 68.05 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202568.05
Mar202436.80
Mar202319.39
Mar202223.41
Mar202127.87

How is EV/Core EBITDA of SUVEN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 68.05
84.92
Mar2024 36.8
89.79
Mar2023 19.39
-17.17
Mar2022 23.41
-16.00
Mar2021 27.87 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹12,038.5 Cr -0.3% -18.1% -70.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹107,358.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 1% 10.8% 4.7% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-0.3%

-18.1%

-70.9%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses